Myeloablative conditioning regimens for AML allografts: 30 years later
In children and adolescents, the pharmacodynamics of high-dose busulfan is dependent on the second alkylating agent used in the combined regimen (melphalan or thiotepa)
Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry
Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
Factors affecting reconstitution of the T cell compartment in allogeneic haematopoietic cell transplant recipients
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb® immunoadsorption
Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation
Nonlethal transfusion associated graft-versus-host disease in a severe combined immunodeficient patient
CO2 laser in oral graft-versus-host disease: a pilot study
Dosing schedule of oral valacyclovir for prevention of herpes simplex virus
Monitoring cyclosporine using blood drawn via a central venous catheter